Immunotherapy research in B’luru gaining momentum – The New Indian Express
|
Immunotherapy research in B'luru gaining momentum
The New Indian Express iCREST, the HCG wing for cellular therapies (immunotherapy), is currently carrying out work targeting it for patients who have failed first line therapies or have contraindications, he said. (A contraindication is a situation in which a drug, procedure … |
